| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.0054 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.0042 | 1 |